MTIM
TEVA icon

Marathon Trading Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Marathon Trading Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-105,300
Closed -$6.22M – 423
2015
Q2 		$6.22M Buy
105,300
+15,000
+17% +$925K 0.25% 67
2015
Q1 		$5.63M Buy
+90,300
New +$5.25M 0.29% 65

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marathon Trading Investment Management's TEVA Position: Q1 2019 in Review

Marathon Trading Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2019, closing a stake of 37,400 shares — an estimated $577K sold.

Marathon Trading Investment Management first reported a position in TEVA in Q4 2014 and held it in 8 quarters. The position peaked at $2.75M in Q4 2014. 522 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

  • Marathon Trading Investment Management reported no remaining Teva Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Marathon Trading Investment Management sold 37,400 Teva Pharmaceuticals shares in Q1 2019, an estimated $577K.
  • Marathon Trading Investment Management first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 8 quarters.
  • Marathon Trading Investment Management's Teva Pharmaceuticals position peaked at $2.75M in Q4 2014.
  • 522 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2019.

Based on Marathon Trading Investment Management's 13F filing for Q1 2019, filed 14 May 2019.